Onconova Implementation Guide
0.2.0 - ci-build
Onconova Implementation Guide - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
The following value sets have been defined for this implementation guide:
TNM Lymphatic Invasion Categories Value Set
TNM Perineural Invasion Categories Value Set
TNM Residual Tumor Categories Value Set
Codes representing roles for adjunctive therapy in oncology.
Categories of actions taken to mitigate or manage adverse events in oncology.
Drugs or medication categories used in the mitigation process of an adverse event.
Classification of actions to mitigate adverse events affecting a patient's health.
Procedures undertaken to mitigate the impact of an adverse event on a patient's health.
Adjustments made to a patient's treatment plan in response to an adverse event.
Amino acid change types due to a genomic variant. It constraints and expands the original LOINC Answer List LL380-7 to enforce Onconova-compatible codes
Drugs and biological agents used in the treatment of neoplastic diseases.
Imaging methods used in cancer diagnosis and monitoring.
A value set containing codes for various cancer risk assessment methods.
A non-exhaustive value set containing codes that result from risk assessments, i.e., the risk level of the cancer.
The causes of death that are relevant for a cancer patient.
Categorizations of the clinical relevance of a genomic variant
A collection of comorbidity panels relevant to cancer patients.
The consent status of a patient for further use of data in research.
Adverse events classified according to the Common Terminology Criteria for Adverse Events (CTCAE)
Coding DNA change types due to a genomic variant. It constraints and expands the original LOINC Answer List LL380-7 to enforce Onconova-compatible codes
Collection of expected effects when a drug is administered.
Agents to which a patient may have been exposed.
The categorical classifications of the HRD status interpreted from its value..
All possible ICD-10 codes for conditions.
The subset of ICD-O-3 concepts dedicated for describing morphology differentiations.
The subset of ICD-O-3 concepts dedicated for describing morphology behavior.
The subset of ICD-O-3 concepts dedicated for describing morphology topographies.
Bodysites related to an observation
Substances that people use to alter their mental state, often for pleasure or leisure, with effects ranging from relaxation and euphoria to hallucinations and altered perceptions.
A value set representing the types of cancer recurrence, specifically local and regional recurrences.
Smoking status of a patient
Set of surgical procedures relevant to cancer treatment in Onconova.
TNM Distant Metastasis Categories Value Set
TNM Grade Categories Value Set
TNM Grade Category Methods Value Set
TNM Primary Tumor Categories Value Set
TNM Regional Nodes Categories Value Set
TNM Serum Tumor Marker Level Categories Value Set
TNM Venous Invasion Categories Value Set
A set of intents for giving a treatment to a cancer patient
Reasons for terminating a treatment in oncology.
Recommendations that may be made by a tumor board for a cancer patient.
Analytes considered tumor markers.
ValueSet containing LOINC and NCI Thesaurus codes for tumor marker laboratory tests and measurements
The categorical classifications of the TMB status interpreted from its value..
The vital status of a patient
The following code systems have been defined for this implementation guide:
A code system for comorbidity panels relevant to cancer patients.
A code system for consent status relevant to Onconova patients.
A code system for codes that are yet to be determined.